Skip to content

Clinical Efficacy of Multimodal Exercise Telerehabilitation Based on Artificial Intelligence for Chronic Non-specific Low Back Pain: A Randomized Controlled Trial

Efficacy of multimodal exercise intervention on motor function in patients with chronic low back pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073185
Enrollment
Unknown
Registered
2023-07-04
Start date
2023-07-31
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic low back

Interventions

Experimental group:AI-assisted multi-model exercise intervention
Control group:Video guidance multi-model exercise intervention

Sponsors

Zhujiang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of non-specific LBP or discomfort for >3 months, with a Numerical Rating Scale (NRS) >=3 points; 2. Age 18 to 75 years; 3. Right-handed; 4. Possession of a smartphone and the skill to operate WeChat.

Exclusion criteria

Exclusion criteria: 1. Fracture population or at risk of fracture: (1) Trauma; (2) Associated pain; (3) Osteoporosis; (4) Steroid intake; (5) Acute spinal deformity; (6) Congenital spinal deformity; (7) Recent spinal surgery (<12 months) or more than two previous spinal surgeries; (8) Spinal pathology, such as spinal stenosis or esthesis or fracture, fusion above 3 segments; (9) Bone tenderness. 2. People with inflammation or those at risk of inflammation: (1) Chronic dull onset pain; (2) Stiffness over 30 minutes; (3) Severe morning; (4) Severe rest, relief after activity; (5) Involving multiple joints; (6) Redness and fever; (7) Limited persistent activity of joints; (8) NSAIDs can relieve symptoms. 3. Infected people or those at risk of infection: (1) Open wounds; (2) Immunosuppression; (3) Postoperative; (4) Fever and night sweats; (5) Urethral infection; (6) Systemic infection. 4. People with neurological diseases: (1) Acute radiculopathy or nerve root injury; (2) Secondary defecation disorder; (3) Loss of sensation in the saddle region; (4) Sock numbness; (5) Clumsy movements; (6) Instability; (7) Widespread progressive phenomena; (8) Gait change. 5. People with high risk of cancer or cancer: (1) Intermittent pain; (2) Insidious onset; (3) Unexplained weight loss; (4) Past cancer; (5) Related family history. 6. Others: (1) Systemic metabolic disorders; (2) Neuromuscular degenerative diseases; (3) Cardiopulmonary or pulmonary disorders with exercise contraindications; (4) Assisted walking or unable to walk more than 300m; (5) Pregnancy; (6) Excluding other neurological, cardiovascular, psychological and musculoskeletal diseases affecting the test.

Design outcomes

Secondary

MeasureTime frame
Roland–Morris Disability Questionnaire (RMDQ);Oswestry Disability Index (ODI);Pain Castastrophizing Scale (PCS);Thickness of the transverse abdominus (TrA) and multifidus (MF) muscles;

Primary

MeasureTime frame
Numerical Rating Scale;

Countries

China

Contacts

Public ContactGuozhi Huang

Zhujiang Hospital, Southern Medical University

2802500171@qq.com+86 130 7421 2216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026